Surefire Medical launches cancer drug delivery catheter

Westminister, CO's Surefire Medical launched a drug delivery catheter for for direct-to-tumor embolization procedures. "Chemo- and radioembolization techniques are becoming valuable treatment options in selected patients with unresectable liver tumors. The Precision catheter provides us with a new interventional tool to safely and effectively deliver drug eluting and yttrium-90 microspheres within the tumor," said Dr. Geert Maleux of the department of radiology at University Hospitals in Leuven, Belgium. The company says a study found the device increases drug delivery into tumors by 90% and reduced delivery to healthy tissue. The Precision catheter has a CE mark and FDA clearance, enabling commercialization in the U.S. and Europe. Release